Immunotherapeutic perspective for bispecific antibodies

Author： van Spriel A.B. van Ojik H.H. van de Winkel J.G.J.

Publisher： Elsevier

ISSN： 0167-5699

Source： Immunology Today, Vol.21, Iss.8, 2000-08, pp. : 391-397

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Kinetic analysis of interactions between bispecific monoclonal antibodies and immobilized antigens using a resonant mirror biosensor

By Dmitriev D.A. Massino Y.S. Segal O.L.

Journal of Immunological Methods, Vol. 280, Iss. 1, 2003-09 ,pp. : 183-1202

Elsevier

Access to resources Recommend Favorite

In Vitro Tumor Growth Inhibition by Bispecific Antibodies to Human Transferrin Receptor and Tumor-Associated Antigens Is Augmented by the Iron Chelator Deferoxamine

By Hsieh-Ma S.T. Shi T. Reeder J. Ring D.B.

Clinical Immunology, Vol. 80, Iss. 2, 1996-08 ,pp. : 185-193

Academic Press

Access to resources Recommend Favorite

The study of B cells and antibodies in Japan: a historical perspective

By Kurosaki Tomohiro

International Immunology, Vol. 22, Iss. 4, 2010-04 ,pp. : 217-226

Oxford University Press

Access to resources Recommend Favorite

Immunotherapeutic strategies for EBV-associated malignancies

By Khanna R. Tellam J. Duraiswamy J. Cooper L.

Trends in Molecular Medicine, Vol. 7, Iss. 6, 2001-06 ,pp. : 270-276

Elsevier

Access to resources Recommend Favorite

Interview: Immunotherapeutic manipulation of the tumor microenvironment

By Vignali Dario AA

Immunotherapy, Vol. 5, Iss. 12, 2013-12 ,pp. : 1279-1281

Future Medicine

Access to resources Recommend Favorite